 | • レポートコード：TPM-BG051 • 出版社/出版日：Transparency Market Research / 2018年7月 • レポート形態：英文、PDF、212ページ • 納品方法：Eメール • 産業分類：医薬品 |
| Single User | ￥857,660 (USD5,795) | ▷ お問い合わせ |
| Multi User | ￥1,301,660 (USD8,795) | ▷ お問い合わせ |
| Global Site License | ￥1,745,660 (USD11,795) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本資料は、アルブミン（賦形剤）の世界市場について調べ、アルブミン（賦形剤）の世界規模、市場動向、市場環境、製品別（ヒト血清アルブミン、組換えアルブミン）分析、用途別（ヒト血清アルブミン用途、組換えアルブミン用途、血清アルブミン用途）分析、最終用途別（医薬品・バイオテクノロジー産業、研究機関）分析、アメリカ市場規模、ヨーロッパ市場規模、アジア市場規模、日本市場規模、中国市場規模、関連企業情報などをまとめた調査レポートです。 ・序文・調査範囲・調査手法 ・エグゼクティブサマリー ・アルブミン（賦形剤）の世界市場動向 ・アルブミン（賦形剤）の世界市場環境 ・アルブミン（賦形剤）の世界市場規模 ・アルブミン（賦形剤）の世界市場規模：製品別（ヒト血清アルブミン、組換えアルブミン） ・アルブミン（賦形剤）の世界市場規模：用途別（ヒト血清アルブミン用途、組換えアルブミン用途、血清アルブミン用途） ・アルブミン（賦形剤）の世界市場規模：最終用途別（医薬品・バイオテクノロジー産業、研究機関） ・アルブミン（賦形剤）の世界市場：地域別市場規模・分析 ・アルブミン（賦形剤）の北米市場規模・予測 ・アルブミン（賦形剤）のアメリカ市場規模・予測 ・アルブミン（賦形剤）のヨーロッパ市場規模・予測 ・アルブミン（賦形剤）のアジア市場規模・予測 ・アルブミン（賦形剤）の日本市場規模・予測 ・アルブミン（賦形剤）の中国市場規模・予測 ・アルブミン（賦形剤）のインド市場規模・予測 ・競争状況・関連企業情報 |
Global Albumin (as Excipient) Market: Overview
This report analyzes the global albumin (as excipient) market in terms of its current and future business prospects. Grant of regulatory approvals and subsequent launch of albumin-based products, increasing participation from the pharmaceutical industry in the development and manufacturing of biopharmaceuticals, along with rise in research & development expenditure and increase in consumption of albumin are the key factors driving the growth of the global albumin (as excipient) market. Albumin serves as an important ingredient for formulated proteins and as a component of culture media and other biotech products, ultimately acting as a multifunctional excipient. Use of a well-characterized multifunctional excipient eliminates the time consumed during characterization of each excipient for different functions. This reduces the associated cost, shortens the registration process, and creates a faster route toward the market. Other factors, such as, decrease in issues with variability in quality, lower lot-to-lot and supplier-to-supplier variation, and reduction in the time involved in formulation optimization also drive the demand for albumin as excipient.
This report on albumin (as excipient) market comprises an elaborate executive summary, which includes a market snapshot, providing information on the various segments of the market. It also provides information and data analysis of the global market with respect to its segments based on product, application, end-user and geography. A detailed qualitative analysis of drivers, restraints, and opportunities of the market has been provided in the market overview section of the report. In addition, it comprises competitive matrix and company profiles with business overview to understand the competition in the market. The section also provides market attractiveness analysis, by geography, and market share analysis, in terms of key players, thus presenting a thorough analysis of the overall competitive scenario in the albumin (as excipient) market.
Global Albumin (as Excipient) Market: Key Segments
In terms of product, the global albumin (as excipient) market has been segmented into human serum albumin and recombinant albumin. Based on application, the global market has been divided into human serum albumin applications and recombinant albumin applications. The human serum albumin application segment has further been classified into drug formulation, drug delivery, vaccines, medical device coating, culture medium & stabilizers, diagnostics, and in vitro fertilization. The recombinant albumin segment has further been bifurcated into drug formulation, drug delivery, vaccines, medical device coating, culture medium & stabilizers, diagnostics, and in vitro fertilization. Market size and forecast for each of these segments have been provided in terms of US$ Mn for the period of 2016 to 2026, along with their respective CAGRs, for the forecast period of 2018 to 2026, considering 2017 as the base year.
Global Albumin (as Excipient) Market: Regional Outlook
Geographically, the global albumin (as excipient) market has been categorized into four major regions and key countries in the respective regions: North America (the U.S. and Canada), Europe (the U.K., Germany, France, Spain, Italy, and Rest of Europe), Asia Pacific (India, China, Japan, Australia, and Rest of Asia Pacific), Rest of the World (Brazil, Mexico, South Africa, Saudi Arabia). Market size and forecast for each of these regions and countries have been provided for the period of 2016 to 2026, along with their respective CAGRs for the forecast period of 2018 to 2026, considering 2017 as the base year. The research study also covers the competitive scenario of the albumin (as excipient) market in these regions.
Companies Profiled in the Report
The report also profiles major players operating in the global albumin (as excipient) market based on various attributes, such as, company overview, financial overview, product portfolio, business strategies, and recent developments. Major players in the market are Albumedix A/S (Novozyme A/S), Albumin Therapeutics, LLC, Biotest AG, CSL Behring LLC, Grifols International, S.A, HiMedia Laboratories Pvt. Ltd., InVitria, Medxbio Pte Ltd, Octapharma AG, RayBiotech, Inc., SeraCare Life Sciences, and Sigma-Aldrich Co. (Merck KGaA).
The global albumin (as excipient) market has been segmented as given below:
Product
Human Serum Albumin
Recombinant Albumin
Application
Human Serum Albumin Applications
Drug Formulation
Drug Delivery
Vaccines
Medical Device Coating
Culture Medium & Stabilizer
Diagnostics
In Vitro Fertilization
Recombinant Albumin Applications
Serum Albumin Applications
Drug Formulation
Drug Delivery
Vaccines
Medical Device Coating
Culture Medium & Stabilizer
Diagnostics
In Vitro Fertilization
End-user
Pharmaceutical & Biotechnology Industry
Research Institutes
Others
Global Pediatric Health Care Products and Services Market, by Geography
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Spain
Rest of Europe
Asia Pacific
China
Japan
India
Australia
Rest of Asia Pacific
Rest of the World
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Albumin (as Excipient) Market
4. Market Overview
4.1. Introduction
4.1.1. Product Type Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Albumin (as Excipient) Market Analysis and Forecast, 2016–2026
4.4.1. Market Revenue Projections (US$ Mn)
4.4.2. Market Volume Shipments Projections
4.5. Porter’s Five Force Analysis
5. Market Outlook
5.1. Key Trends
5.2. Competition Landscape Analysis (Based on Recent Developments of Key Players)
5.3. Pricing Assessment, by Product Type
6. Global Albumin (as Excipient) Market Analysis and Forecast, by Product Type
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value and Volume Forecast, by Product Type, 2016–2026
6.3.1. Human Serum Albumin
6.3.2. Recombinant Albumin
6.4. Market Attractiveness, by Product Type
7. Global Albumin (as Excipient) Market Analysis and Forecast, by Application
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value and Volume Forecast, by Application, 2016–2026
7.3.1. Human Serum Albumin Applications
7.3.1.1. Drug Formulation
7.3.1.2. Drug Delivery
7.3.1.3. Vaccines
7.3.1.4. Medical Device Coating
7.3.1.5. Culture Media & Stabilizers
7.3.1.6. Diagnostics
7.3.1.7. In Vitro Fertilization
7.3.2. Recombinant Albumin Applications
7.3.2.1. Drug Formulation
7.3.2.2. Drug Delivery
7.3.2.3. Vaccines
7.3.2.4. Medical Device Coating
7.3.2.5. Culture Media & Stabilizers
7.3.2.6. Diagnostics
7.3.2.7. In Vitro Fertilization
7.4. Market Attractiveness, by Application
8. Global Albumin (as Excipient) Market Analysis and Forecast, by End-user
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Market Value Forecast, by End-user, 2016–2026
8.3.1. Pharmaceutical & Biotechnology Industry
8.3.2. Research Institutes
8.3.3. Others
8.4. Market Attractiveness, by End-user
9. Global Albumin (as Excipient) Market Analysis and Forecast, by Region
9.1. Key Findings
9.2. Market Value and Volume Forecast, by Region
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Rest of the World
9.3. Market Attractiveness, by Country/Region
10. North America Albumin (as Excipient) Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value and Volume Forecast, by Product Type, 2016–2026
10.2.1. Human Serum Albumin
10.2.2. Recombinant Albumin
10.3. Market Value and Volume Forecast, by Application, 2016–2026
10.3.1. Human Serum Albumin Applications
10.3.1.1. Drug Formulation
10.3.1.2. Drug Delivery
10.3.1.3. Vaccines
10.3.1.4. Medical Device Coating
10.3.1.5. Culture Media & Stabilizers
10.3.1.6. Diagnostics
10.3.1.7. In Vitro Fertilization
10.3.2. Recombinant Albumin Applications
10.3.2.1. Drug Formulation
10.3.2.2. Drug Delivery
10.3.2.3. Vaccines
10.3.2.4. Medical Device Coating
10.3.2.5. Culture Media & Stabilizers
10.3.2.6. Diagnostics
10.3.2.7. In Vitro Fertilization
10.4. Market Value Forecast, by End-user, 2016–2026
10.4.1. Pharmaceutical & Biotechnology Industry
10.4.2. Research Institutes
10.4.3. Others
10.5. Market Value and Volume Forecast, by Country, 2016–2026
10.5.1. U.S.
10.5.2. Canada
10.6. Market Attractiveness Analysis
10.6.1. by Product Type
10.6.2. by Application
10.6.3. by End-user
10.6.4. by Country
11. Europe Albumin (as Excipient) Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value and Volume Forecast, by Product Type, 2016–2026
11.2.1. Human Serum Albumin
11.2.2. Recombinant Albumin
11.3. Market Value and Volume Forecast, by Application, 2016–2026
11.3.1. Human Serum Albumin Applications
11.3.1.1. Drug Formulation
11.3.1.2. Drug Delivery
11.3.1.3. Vaccines
11.3.1.4. Medical Device Coating
11.3.1.5. Culture Media & Stabilizers
11.3.1.6. Diagnostics
11.3.1.7. In Vitro Fertilization
11.3.2. Recombinant Albumin Applications
11.3.2.1. Drug Formulation
11.3.2.2. Drug Delivery
11.3.2.3. Vaccines
11.3.2.4. Medical Device Coating
11.3.2.5. Culture Media & Stabilizers
11.3.2.6. Diagnostics
11.3.2.7. In Vitro Fertilization
11.4. Market Value Forecast, by End-user, 2016–2026
11.4.1. Pharmaceutical & Biotechnology Industry
11.4.2. Research Institutes
11.4.3. Others
11.5. Market Value and Volume Forecast, by Country, 2016–2026
11.5.1. Germany
11.5.2. U.K.
11.5.3. France
11.5.4. Spain
11.5.5. Italy
11.5.6. Rest of Europe
11.6. Market Attractiveness Analysis
11.6.1. by Product Type
11.6.2. by Application
11.6.3. by End-user
11.6.4. by Country
12. Asia Pacific Albumin (as Excipient) Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value and Volume Forecast, by Product Type, 2016–2026
12.2.1. Human Serum Albumin
12.2.2. Recombinant Albumin
12.3. Market Value and Volume Forecast, by Application, 2016–2026
12.3.1. Human Serum Albumin Applications
12.3.1.1. Drug Formulation
12.3.1.2. Drug Delivery
12.3.1.3. Vaccines
12.3.1.4. Medical Device Coating
12.3.1.5. Culture Media & Stabilizers
12.3.1.6. Diagnostics
12.3.1.7. In Vitro Fertilization
12.3.2. Recombinant Albumin Applications
12.3.2.1. Drug Formulation
12.3.2.2. Drug Delivery
12.3.2.3. Vaccines
12.3.2.4. Medical Device Coating
12.3.2.5. Culture Media & Stabilizers
12.3.2.6. Diagnostics
12.3.2.7. In Vitro Fertilization
12.4. Market Value Forecast, by End-user, 2016–2026
12.4.1. Pharmaceutical & Biotechnology Industry
12.4.2. Research Institutes
12.4.3. Others
12.5. Market Value and Volume Forecast, by Country, 2016–2026
12.5.1. China
12.5.2. Japan
12.5.3. India
12.5.4. Australia & New Zealand
12.5.5. Rest of Asia Pacific
12.6. Market Attractiveness Analysis
12.6.1. by Product Type
12.6.2. by Application
12.6.3. by End-user
12.6.4. by Country
13. Rest of the World Albumin (as Excipient) Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value and Volume Forecast, by Product Type, 2016–2026
13.2.1. Human Serum Albumin
13.2.2. Recombinant Albumin
13.3. Market Value and Volume Forecast by Application, 2016–2026
13.3.1. Human Serum Albumin Applications
13.3.1.1. Drug Formulation
13.3.1.2. Drug Delivery
13.3.1.3. Vaccines
13.3.1.4. Medical Device Coating
13.3.1.5. Culture Media & Stabilizers
13.3.1.6. Diagnostics
13.3.1.7. In Vitro Fertilization
13.3.2. Recombinant Albumin Applications
13.3.2.1. Drug Formulation
13.3.2.2. Drug Delivery
13.3.2.3. Vaccines
13.3.2.4. Medical Device Coating
13.3.2.5. Culture Media & Stabilizers
13.3.2.6. Diagnostics
13.3.2.7. In Vitro Fertilization
13.4. Market Value Forecast, by End-user, 2016–2026
13.4.1. Pharmaceutical & Biotechnology Industry
13.4.2. Research Institutes
13.4.3. Others
13.6. Market Attractiveness Analysis
13.6.1. by Product Type
13.6.2. by Application
13.6.3. by End-user
14. Competition Landscape
14.1. Market Player – Competition Matrix (by Tier and Size of Companies)
14.2. Market Share Analysis, by Company (2017)
14.3. Company Profiles
14.3.1. Albumedix A/S (Novozyme A/S)
14.3.1.1. Overview (HQ, Employee Strength, Business Segments)
14.3.1.2. Financials
14.3.1.3. Recent Developments
14.3.1.4. Strategy
14.3.2. Albumin Therapeutics, LLC
14.3.2.1. Overview (HQ, Employee Strength, Business Segments)
14.3.2.2. Financials
14.3.2.3. Recent Developments
14.3.2.4. Strategy
14.3.3. Biotest AG
14.3.3.1. Overview (HQ, Employee Strength, Business Segments)
14.3.3.2. Financials
14.3.3.3. Recent Developments
14.3.3.4. Strategy
14.3.4. CSL Behring LLC
14.3.4.1. Overview (HQ, Employee Strength, Business Segments)
14.3.4.2. Financials
14.3.4.3. Recent Developments
14.3.4.4. Strategy
14.3.5. Grifols International, S.A
14.3.5.1. Overview (HQ, Employee Strength, Business Segments)
14.3.5.2. Financials
14.3.5.3. Recent Developments
14.3.5.4. Strategy
14.3.6. HiMedia Laboratories Pvt. Ltd.
14.3.6.1. Overview (HQ, Employee Strength, Business Segments)
14.3.6.2. Financials
14.3.6.3. Recent Developments
14.3.6.4. Strategy
14.3.7. InVitria
14.3.7.1. Overview (HQ, Employee Strength, Business Segments)
14.3.7.2. Financials
14.3.7.3. Recent Developments
14.3.7.4. Strategy
14.3.8. Medxbio Pte Ltd.
14.3.8.1. Overview (HQ, Employee Strength, Business Segments)
14.3.8.2. Financials
14.3.8.3. Recent Developments
14.3.8.4. Strategy
14.3.9. Octapharma AG
14.3.9.1. Overview (HQ, Employee Strength, Business Segments)
14.3.9.2. Financials
14.3.9.3. Recent Developments
14.3.9.4. Strategy
14.3.10. RayBiotech, Inc.
14.3.10.1. Overview (HQ, Employee Strength, Business Segments)
14.3.10.2. Financials
14.3.10.3. Recent Developments
14.3.10.4. Strategy
14.3.11. SeraCare Life Sciences
14.3.11.1. Overview (HQ, Employee Strength, Business Segments)
14.3.11.2. Financials
14.3.11.3. Recent Developments
14.3.11.4. Strategy
14.3.12. Sigma-Aldrich Co. (Merck KGaA)
14.3.12.1. Overview (HQ, Employee Strength, Business Segments)
14.3.12.2. Financials
14.3.12.3. Recent Developments
14.3.12.4. Strategy
Table 01: Global Albumin (as Excipient) Market Value (US$ Mn) Forecast, by Product, 2016–2026
Table 02: Global Albumin (as Excipient) Market Volume (Kg) Forecast, by Product, 2016–2026
Table 03: Global Albumin (as Excipient) Market Size (US$ Mn) Forecast, by Application, 2016–2026
Table 04: Global Albumin (as Excipient) Market Value (US$ Mn) Forecast, by Application (Human Serum Albumin Applications), 2016–2026
Table 05: Global Albumin (as Excipient) Market Volume (Kg) Forecast, by Application (Human Serum Albumin Applications), 2016–2026
Table 06: Global Albumin (as Excipient) Market Value (US$ Mn) Forecast, by Application (Recombinant Albumin Applications), 2016–2026
Table 07: Global Albumin (as Excipient) Market Volume (Kg) Forecast, by Application (Recombinant Albumin Applications), 2016–2026
Table 08: Global Albumin (as Excipient) Market Size (US$ Mn) Forecast, by End-user, 2016–2026
Table 09: Global Albumin (as Excipient) Market Size (US$ Mn) Forecast, by Region, 2016–2026
Table 10: Global Albumin (as Excipient) Market Volume (Kg) Forecast, by Region, 2016–2026
Table 11: North America Albumin (as Excipient) Market Value (US$ Mn) Forecast, by Country, 2016–2026
Table 12: North America Albumin (as Excipient) Market Volume (kg) Forecast, by Country, 2016–2026
Table 13: North America Albumin (as Excipient) Market Value (US$ Mn) Forecast, by Product, 2016–2026
Table 14: North America Albumin (as Excipient) Market Volume (Kg) Forecast, by Product, 2016–2026
Table 15: North America Albumin (as Excipient) Market Value (US$ Mn) Forecast, by Human Serum Albumin Applications, 2016–2026
Table 16: North America Albumin (as Excipient) Market Volume (Kg) Forecast, by Human Serum Albumin Applications, 2016–2026
Table 17: North America Albumin (as Excipient) Market Value (US$ Mn) Forecast, by Recombinant Albumin Applications, 2016–2026
Table 18: North America Albumin (as Excipient) Market Volume (Kg) Forecast, by Recombinant Albumin Applications, 2016–2026
Table 19: North America Albumin (as Excipient) Market Size (US$ Mn) Forecast, by End-user, 2016–2026
Table 20: Europe Albumin (as Excipient) Market Value (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
Table 21: Europe Albumin (as Excipient) Market Volume (Kg) Forecast, by Country/Sub-region, 2016–2026
Table 22: Europe Albumin (as Excipient) Market Value (US$ Mn) Forecast, by Product, 2016–2026
Table 23: Europe Albumin (as Excipient) Market Volume (Kg) Forecast, by Product, 2016–2026
Table 24: Europe Albumin (as Excipient) Market Value (US$ Mn) Forecast, by Human Serum Albumin Applications, 2016–2026
Table 25: Europe Albumin (as Excipient) Market Volume (Kg) Forecast, by Human Serum Albumin Applications, 2016–2026
Table 26: Europe Albumin (as Excipient) Market Value (US$ Mn) Forecast, by Recombinant Albumin Applications, 2016–2026
Table 27: Europe Albumin (as Excipient) Market Volume (Kg) Forecast, by Recombinant Albumin Applications, 2016–2026
Table 28: Europe Albumin (as Excipient) Market Size (US$ Mn) Forecast, by End-user, 2016–2026
Table 29: Asia Pacific Albumin (as Excipient) Market Value (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
Table 30: Asia Pacific Albumin (as Excipient) Market Volume (kg) Forecast, by Country/Sub-region, 2016–2026
Table 31: Asia Pacific Albumin (as Excipient) Market Value (US$ Mn) Forecast, by Product, 2016–2026
Table 32: Asia Pacific Albumin (as Excipient) Market Volume (Kg) Forecast, by Product, 2016–2026
Table 33: Asia Pacific Albumin (as Excipient) Market Value (US$ Mn) Forecast, by Human Serum Albumin Applications, 2016–2026
Table 34: Asia Pacific Albumin (as Excipient) Market Volume (Kg) Forecast, by Human Serum Albumin Applications, 2016–2026
Table 35: Asia Pacific Albumin (as Excipient) Market Value (US$ Mn) Forecast, by Recombinant Albumin Applications, 2016–2026
Table 36: Asia Pacific Albumin (as Excipient) Market Volume (Kg) Forecast, by Recombinant Albumin Applications, 2016–2026
Table 37: Asia Pacific Albumin (as Excipient) Market Size (US$ Mn) Forecast, by End-user, 2016–2026
Table 38: Rest of the World Albumin (as Excipient) Market Value (US$ Mn) Forecast, by Product, 2016–2026
Table 39: Rest of the World Albumin (as Excipient) Market Volume (Kg) Forecast, by Product, 2016–2026
Table 40: Rest of the World Albumin (as Excipient) Market Value (US$ Mn) Forecast, by Human Serum Albumin Applications, 2016–2026
Table 41: Rest of the World Albumin (as Excipient) Market Volume (Kg) Forecast, by Human Serum Albumin Applications, 2016–2026
Table 42: Rest of the World Albumin (as Excipient) Market Value (US$ Mn) Forecast, by Recombinant Albumin Applications, 2016–2026
Table 43: Rest of the World Albumin (as Excipient) Market Volume (Kg) Forecast, by Recombinant Albumin Applications, 2016–2026
Table 44: Rest of the World Albumin (as Excipient) Market Size (US$ Mn) Forecast, by End-user, 2016–2026